HSP90AA4P as A Potential Drug Target for Various Diseases (G3323)

Target Name: HSP90AA4P

NCBI ID: G3323

HSP90AA4P

Other Name(s): Heat shock protein 90 alpha family class A member 4, pseudogene | HSP90Ad | heat shock protein 90 alpha family class A member 4, pseudogene | HSPCAL2

HSP90AA4P as A Potential Drug Target for Various Diseases

Heat shock protein 90 alpha (HSP90Ad) is a protein that is expressed in various cell types and is involved in a variety of cellular processes. HSP90Ad has been identified as a potential drug target due to its role in a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

HSP90Ad is a member of the HSP90 protein family, which is a group of proteins that are involved in the regulation of thermal stability. These proteins are able to withstand high temperatures and are thought to play a role in the stress response of cells. HSP90Ad is a pseudogene, which means that it is a genetic copy of a gene that is not actually present in the cell.

HSP90Ad has been shown to play a role in a variety of cellular processes, including cell signaling, DNA replication, and stress response. It is also involved in the regulation of cell adhesion, which is the process by which cells stick together and form tissues. HSP90Ad has been shown to play a role in regulating cell adhesion by interacting with cadherins, which are a type of transmembrane protein that is involved in cell-cell adhesion.

In addition to its role in cell signaling and adhesion, HSP90Ad is also involved in the regulation of cell cycle progression. It is a component of the microtubules, which are the protein structures that organize the cells of the cell. These microtubules are involved in the regulation of cell cycle progression, and HSP90Ad has been shown to play a role in this process.

HSP90Ad has also been shown to be involved in a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. For example, studies have shown that HSP90伪 is overexpressed in a variety of cancer cells, and that inhibiting its activity may be a useful strategy for cancer treatment. HSP90Ad has also been shown to be involved in neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease. In these conditions, HSP90Ad has been shown to contribute to the progression of the disease and to play a role in the development of neurodegeneration.

In addition to its role in disease, HSP90伪 is also a potential drug target. Studies have shown that HSP90Ad is able to interact with a variety of small molecules, including drugs that are currently being used to treat a variety of diseases. For example, HSP90Ad has been shown to interact with rapamycin, a drug that is used to treat a variety of conditions, including cancer and neurodegenerative diseases.

Furthermore, HSP90Ad has also been shown to interact with inhibitors of its activity, such as the drug tirapazam. These interactions may be useful for the development of drugs that are able to inhibit HSP90Ad's activity and are being used to treat a variety of diseases.

In conclusion, HSP90Ad is a protein that is involved in a variety of cellular processes and has been identified as a potential drug target due to its role in a variety of diseases. Studies have shown that HSP90Ad is able to interact with a variety of small molecules and inhibitors of its activity, making it an attractive target for drug development. Further research is needed to fully understand the role of HSP90Ad in disease and to develop effective treatments.

Protein Name: Heat Shock Protein 90 Alpha Family Class A Member 4, Pseudogene

Functions: Putative molecular chaperone that may promote the maturation, structural maintenance and proper regulation of specific target proteins

The "HSP90AA4P Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about HSP90AA4P comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets